CryoLife Company Profile (NYSE:CRY)

About CryoLife

CryoLife logoCryoLife, Inc. (CryoLife) is engaged in medical device manufacturing and distribution, and in the processing and distribution of implantable human tissues for cardiac and vascular surgeries. The Company operates in two segments: Medical Devices and Preservation Services. The Medical Devices segment sells BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, Hemodialysis Reliable Outflow (HeRO) Graft, and ProCol Vascular Bioprosthesis (ProCol). The Preservation Services segment preserves cardiac and vascular tissues. The Company's surgical sealants and hemostats include BioGlue Surgical Adhesive (BioGlue), BioFoam Surgical Matrix (BioFoam), and PerClot, an absorbable powdered hemostat, which the Company distributes internationally for Starch Medical, Inc. (SMI). Its CardioGenesis cardiac laser therapy product line includes a laser console system and single-use, fiber-optic handpieces.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NYSE
  • Symbol: CRY
  • CUSIP: 22890310
Key Metrics:
  • Previous Close: $15.38
  • 50 Day Moving Average: $13.69
  • 200 Day Moving Average: $11.94
  • Trailing P/E Ratio: 49.29
  • Foreward P/E Ratio: 49.61
  • P/E Growth: 2.16
  • Market Cap: $524.61M
  • Outstanding Shares: 34,110,000
  • Beta: 1.2
Additional Links:
Companies Related to CryoLife:

Analyst Ratings

Consensus Ratings for CryoLife (NYSE:CRY) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $14.25 (7.35% downside)

Analysts' Ratings History for CryoLife (NYSE:CRY)
DateFirmActionRatingPrice TargetDetails
7/27/2016Piper Jaffray Cos.Reiterated RatingOverweight$16.00View Rating Details
7/26/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/15/2016Lake Street CapitalInitiated CoverageBuy$15.00View Rating Details
4/28/2016Ladenburg ThalmannDowngradeBuy -> Neutral$12.00View Rating Details
5/18/2015First AnalysisInitiated CoverageOverweight$14.00View Rating Details
(Data available from 8/25/2014 forward)


Earnings History for CryoLife (NYSE:CRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2016Q216$0.02$0.13$35.50 million$47.10 millionViewListenView Earnings Details
4/27/2016Q116$0.02$0.10$40.50 million$43.00 millionViewListenView Earnings Details
2/16/2016Q415$0.05$0.13$40.04 million$39.80 millionViewListenView Earnings Details
10/27/2015Q315$0.01$0.10$38.17 million$36.70 millionViewListenView Earnings Details
7/28/2015Q215$0.03$35.57 million$35.50 millionViewListenView Earnings Details
4/28/2015Q115$0.01($0.01)$36.55 million$33.80 millionViewListenView Earnings Details
2/17/2015Q414$0.05$0.04$37.42 million$37.20 millionViewListenView Earnings Details
10/28/2014Q314$0.05$0.08$37.70 million$37.10 millionViewListenView Earnings Details
7/24/2014Q214$0.05$0.08$35.72 million$34.69 millionViewListenView Earnings Details
4/29/2014Q114$0.07$0.04$37.30 million$35.73 millionViewListenView Earnings Details
2/20/2014Q413$0.35$0.31$34.90 million$35.50 millionViewListenView Earnings Details
10/29/2013Q313$0.05$0.12$35.51 million$36.30 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.07$0.08$35.63 million$33.50 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.07$0.08$35.04 million$35.50 millionViewListenView Earnings Details
2/14/2013Q4 2012$0.05$0.08$33.58 million$32.80 millionViewListenView Earnings Details
10/30/2012Q312$0.04$0.08$32.45 million$33.40 millionViewN/AView Earnings Details
7/31/2012$0.05$0.10ViewN/AView Earnings Details
4/26/2012$0.05$0.04ViewN/AView Earnings Details
2/16/2012$0.06$0.07ViewN/AView Earnings Details
10/27/2011$0.08$0.07ViewN/AView Earnings Details
7/28/2011$0.06$0.12ViewN/AView Earnings Details
4/28/2011$0.08$0.09ViewN/AView Earnings Details
2/17/2011$0.07$0.08ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CryoLife (NYSE:CRY)
Current Year EPS Consensus Estimate: $0.24 EPS
Next Year EPS Consensus Estimate: $0.31 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.01$0.01$0.01
Q2 20162$0.01$0.02$0.02
Q3 20162$0.01$0.04$0.03
Q4 20162$0.02$0.07$0.05
Q1 20172$0.04$0.06$0.05
Q2 20172$0.07$0.07$0.07
Q3 20171$0.07$0.07$0.07
Q4 20171$0.09$0.09$0.09
(Data provided by Zacks Investment Research)


Current Dividend Information for CryoLife (NYSE:CRY)
Annual Dividend:$0.06
Dividend Yield:0.39%
Payout Ratio:19.35% (Based on Trailing 12 Months of Earnings)
25.00% (Based on Current Year Consensus EPS Estimate)
19.35% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:33.90% (3 Year Average)

Dividend History for CryoLife (NYSE:CRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for CryoLife (NYSE:CRY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/26/2016C Elkins RonaldDirectorSell2,000$14.00$28,000.00View SEC Filing  
6/1/2016Ronald D MccallDirectorSell10,000$11.56$115,600.00View SEC Filing  
5/10/2016James BensonDirectorSell5,000$12.22$61,100.00View SEC Filing  
4/15/2016C Elkins RonaldDirectorSell1,000$12.00$12,000.00View SEC Filing  
3/7/2016C Elkins RonaldDirectorSell2,000$11.18$22,360.00View SEC Filing  
3/4/2016James P MackinCEOBuy10,000$10.91$109,100.00View SEC Filing  
2/19/2016Scott B CappsVPSell15,000$10.30$154,500.00View SEC Filing  
2/18/2016David Ashley LeeCFOSell8,000$10.13$81,040.00View SEC Filing  
12/28/2015David Ashley LeeCFOSell700$11.00$7,700.00View SEC Filing  
11/30/2015David Ashley LeeCFOSell11,800$11.03$130,154.00View SEC Filing  
9/15/2015James BensonDirectorSell5,839$9.65$56,346.35View SEC Filing  
9/11/2015James BensonDirectorSell3,359$9.65$32,414.35View SEC Filing  
2/19/2015Steven G AndersonChairmanSell30,000$10.93$327,900.00View SEC Filing  
12/9/2014Bruce G AndersonVPSell3,900$10.29$40,131.00View SEC Filing  
11/25/2014Bruce G AndersonVPSell20,211$10.11$204,333.21View SEC Filing  
11/5/2014C Elkins RonaldDirectorSell4,000$10.08$40,320.00View SEC Filing  
11/3/2014James BensonDirectorSell10,000$10.22$102,200.00View SEC Filing  
9/8/2014Bruce G AndersonVPSell10,000$10.05$100,500.00View SEC Filing  
9/2/2014Steven G AndersonChairmanSell20,000$10.08$201,600.00View SEC Filing  
8/25/2014Bruce G AndersonVPSell5,000$10.05$50,250.00View SEC Filing  
8/18/2014Bruce G AndersonVPSell10,000$10.52$105,200.00View SEC Filing  
8/14/2014David Ashley LeeCFOSell10,000$10.51$105,100.00View SEC Filing  
8/13/2014David Ashley LeeCFOSell9,881$10.51$103,849.31View SEC Filing  
8/13/2014Jeffrey W BurrisVPSell11,000$10.50$115,500.00View SEC Filing  
7/29/2014C Elkins RonaldDirectorSell2,500$9.67$24,175.00View SEC Filing  
7/28/2014Bruce G AndersonVPSell5,000$9.48$47,400.00View SEC Filing  
7/28/2014Steven G AndersonCEOSell19,477$9.52$185,421.04View SEC Filing  
6/9/2014Amy HortonCAOSell2,500$9.26$23,150.00View SEC Filing  
5/16/2014David FronkVPSell8,952$8.61$77,076.72View SEC Filing  
5/13/2014Steven AndersonCEOSell30,523$9.00$274,707.00View SEC Filing  
5/6/2014Bruce AndersonVPSell16,870$8.83$148,962.10View SEC Filing  
11/26/2013Jeffrey BurrisVPSell5,000$10.50$52,500.00View SEC Filing  
11/11/2013Jeffrey BurrisVPSell5,000$10.00$50,000.00View SEC Filing  
11/7/2013Steven AndersonCEOSell100,000$9.38$938,000.00View SEC Filing  
10/29/2013C Elkins RonaldDirectorSell2,000$9.00$18,000.00View SEC Filing  
10/29/2013Jeffrey W BurrisVPSell5,000$9.00$45,000.00View SEC Filing  
8/27/2013Bruce AndersonVPSell4,500$6.33$28,485.00View SEC Filing  
8/8/2013Amy HortonCAOSell2,500$7.07$17,675.00View SEC Filing  
8/1/2013Ronald D MccallDirectorSell6,000$7.10$42,600.00View SEC Filing  
6/6/2013Ronald D MccallDirectorSell4,000$6.15$24,600.00View SEC Filing  
5/31/2013C Elkins RonaldDirectorSell2,250$6.15$13,837.50View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for CryoLife (NYSE:CRY)
News IconSurgical Sealants and Adhesives Market 2016: Industry Review and Growth to 2022 (NYSE:CRY) - August 19 at 10:32 AM logoBioTelemetry (BEAT) Scales New 52-Week High on Solid Q2 (NYSE:CRY) - August 19 at 10:32 AM logo49.9% Return Seen to Date on SmarTrend CryoLife Call (CRY) (NYSE:CRY) - August 19 at 10:32 AM logoCryoLife (CRY) Raised to Strong Buy on Solid Q2 Results (NYSE:CRY) - August 12 at 4:28 PM logoNew Strong Buy Stocks for August 12th (NYSE:CRY) - August 12 at 10:00 AM
News IconReport Published: "Tissue Heart Valves - Medical Devices Pipeline Assessment, 2016" (NYSE:CRY) - August 11 at 4:34 PM logo45.3% Return Seen to Date on SmarTrend CryoLife Call (CRY) (NYSE:CRY) - August 11 at 4:34 PM logoCryoLife to Present at 2016 Wedbush PacGrow Healthcare Conference (NYSE:CRY) - August 11 at 10:19 AM logoBioadhesives Market: Opportunities and Forecasts 2015 to 2021 (NYSE:CRY) - August 5 at 9:44 PM logoCryoLife to Present at 36th Annual Canaccord Genuity Growth Conference (NYSE:CRY) - August 4 at 10:07 PM logoETF’s with exposure to CryoLife, Inc. : August 2, 2016 (NYSE:CRY) - August 2 at 4:32 PM logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 1, 2016 (NYSE:CRY) - August 1 at 4:24 PM logoCRYOLIFE INC Financials (NYSE:CRY) - July 30 at 1:04 PM logoCryolife : Susan Gunderson of St. Paul, Minnesota Receives Achievement Award from Association of Organ Procurement Organizations (NYSE:CRY) - July 30 at 10:38 AM
News IconCryoLife Inc. (CRY) Releases FY16 Earnings Guidance (NYSE:CRY) - July 28 at 11:26 AM logoCryoLife, Inc.: Strong price momentum but will it sustain? (NYSE:CRY) - July 27 at 4:23 PM logoCryoLife, Inc. :CRY-US: Earnings Analysis: Q2, 2016 By the Numbers : July 27, 2016 (NYSE:CRY) - July 27 at 3:04 PM logoCryoLife's (CRY) CEO Patrick Mackin on Q2 2016 Results - Earnings Call Transcript (NYSE:CRY) - July 26 at 10:32 PM logoCRYOLIFE INC : Results of Operations and Financial Condition, Change in Directors or Principal Officers (form 8-K) (NYSE:CRY) - July 26 at 10:32 PM
News IconCryoLife reports Q2 earnings, turns from loss to profit (NYSE:CRY) - July 26 at 10:32 PM logoCryolife Inc (CRY) Post-Earnings Boom Entices Options Players (NYSE:CRY) - July 26 at 10:32 PM logoEdited Transcript of CRY earnings conference call or presentation 26-Jul-16 12:00pm GMT (NYSE:CRY) - July 26 at 6:53 PM logoWhy Cryolife Inc's Shares Turned Hot Today (NYSE:CRY) - July 26 at 1:04 PM logoWhy is Cryolife Inc. (CRY) Surging 14.1% Today? (NYSE:CRY) - July 26 at 12:15 PM logoCryoLife Inc Earnings Call scheduled for 8:00 am ET today (NYSE:CRY) - July 26 at 8:00 AM logoCRYOLIFE INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal Offi (NYSE:CRY) - July 26 at 7:33 AM logoCryoLife Inc Earnings Call (Q2 2016) (NYSE:CRY) - July 25 at 9:11 PM logoCryoLife : Reports Second Quarter 2016 Financial Results (NYSE:CRY) - July 25 at 9:11 PM logoCryoLife Raises 2016 Guidance - Quick Facts (NYSE:CRY) - July 25 at 9:11 PM logoCryolife Inc. Bottom Line Advances 246% In Q2 (NYSE:CRY) - July 25 at 9:11 PM logoCryoLife Reports Second Quarter 2016 Financial Results (NYSE:CRY) - July 25 at 5:48 PM logoCryoLife beats 2Q profit forecasts (NYSE:CRY) - July 25 at 5:43 PM logoCryoLife beats by $0.07, beats on revenue (NYSE:CRY) - July 25 at 5:42 PM logoQ2 2016 CryoLife Inc Earnings Release - After Market Close (NYSE:CRY) - July 25 at 7:07 AM logoMedical Product Stocks Jul 25 Earnings Roster: CRY, VASC (NYSE:CRY) - July 22 at 9:40 AM logoHemostasis And Tissue Sealing Agents Market Analysis By Product (Topical Hemostats, Active, Mechanical, … (NYSE:CRY) - July 21 at 9:56 PM logoCan CryoLife (CRY) Earnings Spring a Surprise in Q2? (NYSE:CRY) - July 21 at 8:36 AM logoCryoLife Inc.: CryoLife Announces Release Date and Teleconference Call Details for 2016 Second Quarter Financial Results (NYSE:CRY) - July 12 at 9:51 PM logoCryoLife Announces Release Date and Teleconference Call Details for 2016 Second Quarter Financial Results (NYSE:CRY) - July 12 at 5:43 PM
News IconBioSurgery Market: Trends Analysis & Forecast – Expected to Hit CAGR Of 8.8% by 2021 (NYSE:CRY) - July 11 at 9:13 AM logoCryoLife, Inc. breached its 50 day moving average in a Bullish Manner : CRY-US : July 4, 2016 (NYSE:CRY) - July 4 at 8:22 AM logoAccuray (ARAY) Receives 510(k) FDA Clearance for Radixact (NYSE:CRY) - June 29 at 11:18 AM
News IconMedical adhesives and sealants market is estimated to expand at a CAGR of 8.5% from 2015 to 2020 according to new research report (NYSE:CRY) - June 28 at 4:22 PM
News IconResearch focused on the fibrin glue market mainly is driven by increasing healthcare expenditure, market supply demand, share from 2014 to 2020 (NYSE:CRY) - June 27 at 4:26 PM logoThe fibrin glue market mainly is driven by increasing healthcare expenditure, Market Supply Demand, share, 2014-2020 (NYSE:CRY) - June 27 at 8:56 AM logoMedical Adhesives Market to Grow at a 10.7% CAGR Forecast to 2022 (NYSE:CRY) - June 24 at 11:07 AM logoOpko Health (OPK) Catches Eye: Stock Adds 5.6% in Session (NYSE:CRY) - June 22 at 8:15 AM logoCryoLife, Inc. – Value Analysis (NYSE:CRY) : June 21, 2016 (NYSE:CRY) - June 21 at 11:23 AM logoCryoLife, Inc. breached its 50 day moving average in a Bearish Manner : CRY-US : June 20, 2016 (NYSE:CRY) - June 20 at 8:34 AM
News IconBiosurgery Market is Expected to Reach $12.7 Billion by 2022 (NYSE:CRY) - June 19 at 4:14 PM


CryoLife (NYSE:CRY) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff